Lehigh Valley Hospital: When It Matters Most lvh.org home page Careers at LVH Education @ LVH For Professionals working with LVH
Breast Health Services

Where You Get Your Mammogram Makes a Difference

Experience: More than 40,000 women choose Breast Health Services for mammograms every year. Each breast radiologist at Lehigh Valley Hospital and Health Network is required to interpret at least 1,200 digital mammograms a year. That's more than double the national benchmark.

Technology: All the latest advances including digital mammography.

Accuracy: More than 80% of cancers are found at their earliest, most treatable stages. The national standard is just 50%.


How Breast Health Services Helps You

Most women experience some type of breast problem during their lifetimes. If you find a lump or change in your breasts, don’t panic. More than 80% of breast disorders are not cancerous. However, your chance of developing breast cancer increases greatly as you get older. And breast cancer has no warning signs. It just appears. That's why examinations are so important.

When Should You Have Breast Exams?
Are you having all three important exams? More >>

Why Mammograms Are Better at Breast Health Services
Detection rates among the most accurate in the nation are just one reason. More >>

How to Do a Breast Self-Exam
Special training can help you find cancer earlier. More >>

When You Have Breast Problems
Breast Health Services has other diagnostic services. More >>

Breast Cancer Information
Breast cancer that's detected early has an excellent survival and cure rate. Even when cancer has spread, there are effective treatment options, with a better quality of life. Our experts can help you decide on options that are right for you. More >>

ARTICLE TOOLS:

email this article to a friend print this article

Click Here to Contact Breast Health Services via Relay Health

Ask Our Expert
Q: I heard the FDA recently approved a drug, Evista, to reduce the risk for breast cancer-is that true? Who can benefit from this medication?
A: Yes, in September the U.S. Food and Drug Administration (FDA) approved Evista (the brand name for raloxifene previously used to treat osteoporosis) to help prevent breast cancer in postmenopausal women who are at high-risk for the disease.

My Story
She’s No Ordinary Patient
Tammy Miller writes a book about the lighter side of breast cancer and features Aaron Bleznak, M.D., as head of her humor team.






hon cod ©2008 Lehigh Valley Hospital and Health Network
LVH Info Line: 610-402-CARE
Cedar Crest & I-78, P.O. Box 689, Allentown, PA 18105-1556

 
Increase the Size of Text by clicking here. Descrease the Size of Text by clicking here Email this story to family and friends. Print this story formatted for your printer.